Publications

Publications published since 2000 or in press from OUS - Department of Infectious Diseases

280 publications found

Publications in press

1. Lind A, Sommerfelt M, Holmberg JO, Baksaas I, Sørensen B, Kvale D
   Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
   Scand J Infect Dis (in press)
   PubMed 22339485
2. Manner IW, Baekken M, Oektedalen O, Os I
   Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
   Blood Press (in press)
   PubMed 22564000

Publications 2012

1. Brantsæter AB (2012)
   [In Process Citation]
   Tidsskr Nor Laegeforen, 132 (6), 614
   PubMed 22456126
2. Damås JK, Bækken M, Ueland T, Manner IW, Os I, Yndestad A, Flo TH, Øktedalen O, Aukrust P (2012)
   Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
   J Acquir Immune Defic Syndr, 59 (2), e24-5
   PubMed 22245717
3. Damås JK, Øktedalen O, Ueland T, Landrø L, Barstad J, Müller F, Frøland SS, Flo TH, Aukrust P (2012)
   Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)
   Clin Exp Immunol, 167 (3), 492-8
   PubMed 22288592
4. Espetvedt MN, Wolff C, Rintakoski S, Lind A, Osterås O (2012)
   Completeness of metabolic disease recordings in Nordic national databases for dairy cows
   Prev Vet Med, 105 (1-2), 25-37
   PubMed 22391018
5. Fagan M, Mæhlen M, Lindbæk M, Berild D (2012)
   Antibiotic prescribing in nursing homes in an area with low prevalence of antibiotic resistance: compliance with national guidelines
   Scand J Prim Health Care, 30 (1), 10-5
   PubMed 22188479
6. Kjetland EF, Leutscher PD, Ndhlovu PD (2012)
   A review of female genital schistosomiasis
   Trends Parasitol, 28 (2), 58-65
   PubMed 22245065
7. Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2012)
   Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection
   APMIS, 120 (3), 204-9
   PubMed 22339677
8. Mørch K, Myrvang B (2012)
   Treatment of malaria in Norway
   Tidsskr Nor Laegeforen, 132 (6), 664-7
   PubMed 22456148
9. Odolini S, Parola P, Gkrania-Klotsas E, Caumes E, Schlagenhauf P, López-Vélez R, Burchard GD, Santos-O'Connor F, Weld L, von Sonnenburg F, Field V, de Vries P, Jensenius M, Loutan L, Castelli F (2012)
   Travel-related imported infections in Europe, EuroTravNet 2009
   Clin Microbiol Infect, 18 (5), 468-474
   PubMed 21848975
10. Tonde AK, Berild D (2012)
    Young woman with lasting back pain
    Tidsskr Nor Laegeforen, 132 (1), 48
    PubMed 22240829
11. Torfoss D, Høiby EA, Holte H, Kvaløy S (2012)
    The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review
    Acta Oncol, 51 (4), 433-40
    PubMed 22175253
12. Wessman M, Westling K, Aho I, Quist-Paulsen E, Wæhre T, Rolfhamre L, Weis N, Katzenstein TL (2012)
    Major differences in assisted reproductive treatments offered to HIV-1 infected patients in the Nordic countries
    Scand J Infect Dis, 44 (5), 402-4
    PubMed 22292615

Publications 2011

1. Berdal JE, Mollnes TE, Wæhre T, Olstad OK, Halvorsen B, Ueland T, Laake JH, Furuseth MT, Maagaard A, Kjekshus H, Aukrust P, Jonassen CM (2011)
   Excessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza
   J Infect, 63 (4), 308-16
   PubMed 21781987
2. Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
   Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
   BMC Infect Dis, 11, 75
   PubMed 21435254
3. Brantsæter AB (2011)
   [Did vaccines and hygiene recommendations affect the pandemic?]
   Tidsskr Nor Laegeforen, 131 (7), 662
   PubMed 21494288
4. Haug JB, Berild D, Walberg M, Reikvam A (2011)
   Increased antibiotic use in Norwegian hospitals despite a low antibiotic resistance rate
   J Antimicrob Chemother, 66 (11), 2643-6
   PubMed 21903657
5. Haug JB, Myhr R, Reikvam A (2011)
   Pharmacy sales data versus ward stock accounting for the surveillance of broad-spectrum antibiotic use in hospitals
   BMC Med Res Methodol, 11, 166
   PubMed 22166018
6. Hesstvedt L, Wilhelmsen M, Mengshoel AT, Dyrhol-Riise AM (2011)
   Two Norwegian patients with melioidosis presenting with bacteraemia and splenic and prostatic abscesses
   J Travel Med, 18 (6), 418-21
   PubMed 22017720
7. Johannessen A (2011)
   Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital-author's response
   J. Antimicrob. Chemother., 66 (4), 957-958
8. Johannessen A (2011)
   Are men the losers of the antiretroviral treatment scale-up?
   AIDS, 25 (9), 1225-6
   PubMed 21593620
9. Johannessen A, Garrido C, Zahonero N, Naman E, de Mendoza C (2011)
   HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System
   J Antimicrob Chemother, 66 (2), 260-4
   PubMed 21115444
10. Johannessen A, Naman E, Gundersen SG, Bruun JN (2011)
    Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania
    BMC Infect Dis, 11, 190
    PubMed 21745396
11. Jourdan PM, Holmen SD, Gundersen SG, Roald B, Kjetland EF (2011)
    HIV target cells in Schistosoma haematobium-infected female genital mucosa
    Am J Trop Med Hyg, 85 (6), 1060-4
    PubMed 22144444
12. Jourdan PM, Roald B, Poggensee G, Gundersen SG, Kjetland EF (2011)
    Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection
    PLoS Negl Trop Dis, 5 (6), e1170
    PubMed 21666790
13. Kivuyo SL, Johannessen A, Trøseid M, Kasubi MJ, Gundersen SG, Naman E, Mushi D, Ngowi BJ, Mfinanga GS, Bruun JN (2011)
    p24 antigen detection on dried blood spots is a feasible and reliable test for infant HIV infection in rural Tanzania
    Int J STD AIDS, 22 (12), 719-21
    PubMed 22174052
14. Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
    An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
    J Virol, 85 (13), 6557-66
    PubMed 21490090
15. Reki? D, Clewe O, Röshammar D, Flamholc L, Sönnerborg A, Ormaasen V, Gisslén M, Abelö A, Ashton M (2011)
    Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy
    AAPS J, 13 (4), 598-605
    PubMed 21913053
16. Röshammar D, Simonsson US, Ekvall H, Flamholc L, Ormaasen V, Vesterbacka J, Wallmark E, Ashton M, Gisslén M (2011)
    Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients
    J Pharmacokinet Pharmacodyn, 38 (6), 727-42
    PubMed 21964996
17. Thomassen M, Mokkelbost T, Sheridan E, Lind A (2011)
    Supported Nanostructured Ir and IrRu Electrocatalysts for Oxygen Evolution in PEM Electrolysers
    ECS TRANSACTIONS, 35 (34), 271-279
18. Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S (2011)
    The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
    Scand J Immunol, 74 (6), 632-9
    PubMed 21883353
19. Trøseid M (2011)
    [In Process Citation]
    Tidsskr Nor Laegeforen, 131 (23), 2331
    PubMed 22139097
20. Trøseid M, Sönnerborg A, Nowak P (2011)
    High mobility group box protein-1 in HIV-1 infection
    Curr HIV Res, 9 (1), 6-10
    PubMed 21198433
21. van der Helm JJ, Prins M, del Amo J, Bucher HC, Chêne G, Dorrucci M, Gill J, Hamouda O, Sannes M, Porter K, Geskus RB, CASCADE Collaboration (2011)
    The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007
    AIDS, 25 (8), 1083-91
    PubMed 21537114

Publications 2010

1. Baekken M, Manner I, Ueland T, Frøland SS, Os I, Aukrust P, Oktedalen O, Damås JK (2010)
   Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
   J Acquir Immune Defic Syndr, 53 (3), 419-20
   PubMed 20190590
2. Behrens RH, Carroll B, Hellgren U, Visser LG, Siikamäki H, Vestergaard LS, Calleri G, Jänisch T, Myrvang B, Gascon J, Hatz C (2010)
   The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator?
   Malar J, 9, 266
   PubMed 20920352
3. Berild D, Lindbaek M (2010)
   Use of antibiotics gives cause for concern
   Tidsskr Nor Laegeforen, 130 (20), 2010
   PubMed 20967030
4. Brandsaeter B, Sabel M, Rui TO (2010)
   [A woman with known anxiety, depression and alcohol abuse]
   Tidsskr Nor Laegeforen, 130 (4), 385-6
   PubMed 20220864
5. Bratholm C, Johannessen A, Naman E, Gundersen SG, Kivuyo SL, Holberg-Petersen M, Ormaasen V, Bruun JN (2010)
   Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital
   J Antimicrob Chemother, 65 (9), 1996-2000
   PubMed 20576637
6. Edén A, Andersson LM, Andersson O, Flamholc L, Josephson F, Nilsson S, Ormaasen V, Svedhem V, Säll C, Sönnerborg A, Tunbäck P, Gisslén M (2010)
   Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected patients
   AIDS Res Hum Retroviruses, 26 (5), 533-40
   PubMed 20455766
7. Field V, Gautret P, Schlagenhauf P, Burchard GD, Caumes E, Jensenius M, Castelli F, Gkrania-Klotsas E, Weld L, Lopez-Velez R, de Vries P, von Sonnenburg F, Loutan L, Parola P, EuroTravNet network (2010)
   Travel and migration associated infectious diseases morbidity in Europe, 2008
   BMC Infect Dis, 10, 330
   PubMed 21083874
8. Gebre-Michael T, Balkew M, Berhe N, Hailu A, Mekonnen Y (2010)
   Further studies on the phlebotomine sandflies of the kala-azar endemic lowlands of Humera-Metema (north-west Ethiopia) with observations on their natural blood meal sources
   Parasit Vectors, 3 (1), 6
   PubMed 20181077
9. Grydeland H, Walhovd KB, Westlye LT, Due-Tønnessen P, Ormaasen V, Sundseth Ø, Fjell AM (2010)
   Amnesia following herpes simplex encephalitis: diffusion-tensor imaging uncovers reduced integrity of normal-appearing white matter
   Radiology, 257 (3), 774-81
   PubMed 20935078
10. Haug JB, Raastad R, Berild D (2010)
    [>Look to Norway>--but for how long?]
    Tidsskr Nor Laegeforen, 130 (15), 1484-6
    PubMed 20706311
11. Holm M, Høstmark KE (2010)
    [Buy a uniform--support a nurse!]
    Tidsskr Nor Laegeforen, 130 (17), 1738-9
    PubMed 20835288
12. Jenum PA, Flesland Ø, Blystad H, Vik IS, Hervig T, Maeland A, Saeter G (2010)
    [Syphilis and blood transfusion]
    Tidsskr Nor Laegeforen, 130 (8), 839-41
    PubMed 20418930
13. Johannessen A (2010)
    Quantification of HIV-1 RNA on dried blood spots
    AIDS, 24 (3), 475-6
    PubMed 20087079
14. Johannessen A (2010)
    Dried blood spots in HIV monitoring: applications in resource-limited settings
    Bioanalysis, 2 (11), 1893-908
    PubMed 21083497
15. Johannessen A, Holberg-Petersen M, Lövgaarden G, Naman E, Ormaasen V, Matee MI, Gundersen SG, Bruun JN (2010)
    HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania
    Antivir Ther, 15 (7), 1003-9
    PubMed 21041915
16. Josephson F, Andersson MC, Flamholc L, Gisslén M, Hagberg L, Ormaasen V, Sönnerborg A, Vesterbacka J, Böttiger Y (2010)
    The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
    Eur J Clin Pharmacol, 66 (4), 349-57
    PubMed 19967342
17. Kjetland EF, Kurewa EN, Mduluza T, Midzi N, Gomo E, Friis H, Gundersen SG, Ndhlovu PD (2010)
    The first community-based report on the effect of genital Schistosoma haematobium infection on female fertility
    Fertil Steril, 94 (4), 1551-3
    PubMed 20149365
18. Kjetland EF, Ndhlovu PD, Mduluza T, Deschoolmeester V, Midzi N, Gomo E, Gwanzura L, Mason PR, Vermorken JB, Friis H, Gundersen SG, Baay MF (2010)
    The effects of genital schistosoma haematobium on human papillomavirus and the development of cervical neoplasia after five years in a Zimbabwean population
    Eur J Gynaecol Oncol, 31 (2), 169-73
    PubMed 20527233
19. Kran AM, Jonassen TO, Sommerfelt MA, Løvgården G, Sørensen B, Kvale D (2010)
    Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides
    AIDS, 24 (17), 2609-18
    PubMed 20935558
20. Lillerud LE, Stuestoel VM, Hoel RE, Rukeba Z, Kjetland EF (2010)
    Exploring the feasibility and possible efficacy of mass treatment and education of young females as schistosomiasis influences the HIV epidemic
    Arch Gynecol Obstet, 281 (3), 455-60
    PubMed 19434416
21. Lind A, Lapinleimu H, Korkman M, Lehtonen L, Parkkola R, Haataja L, PIPARI Study Group (2010)
    Five-year follow-up of prematurely born children with postnatally developing caudothalamic cysts
    Acta Paediatr, 99 (2), 304-7
    PubMed 19832740
22. Manner IW, Baekken M, Oektedalen O, Sandvik L, Os I (2010)
    Effect of HIV duration on ambulatory blood pressure in HIV-infected individuals with high office blood pressure
    Blood Press, 19 (3), 188-95
    PubMed 20482442
23. Mendelson M, Davis XM, Jensenius M, Keystone JS, von Sonnenburg F, Hale DC, Burchard GD, Field V, Vincent P, Freedman DO, GeoSentinel Surveillance Network (2010)
    Health risks in travelers to South Africa: the GeoSentinel experience and implications for the 2010 FIFA World Cup
    Am J Trop Med Hyg, 82 (6), 991-5
    PubMed 20519590
24. Myrvang B (2010)
    [A fifth plasmodium that can cause malaria]
    Tidsskr Nor Laegeforen, 130 (3), 282-3
    PubMed 20160773
25. Pettersen FO, Taskén K, Kvale D (2010)
    Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection
    Clin Exp Immunol, 161 (2), 315-23
    PubMed 20491784
26. Skeie L, Bugge H, Negaard A, Bergersen BM (2010)
    Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study
    HIV Med, 11 (3), 170-7
    PubMed 19780861
27. Storla DG, Yimer S, Bjune GA (2010)
    Can treatment delay be utilized as a key variable for monitoring the pool of infectious tuberculosis in a population?
    J Infect Dev Ctries, 4 (2), 83-90
    PubMed 20212338
28. Trøseid M, Johannessen A (2010)
    [A step in the right direction]
    Tidsskr Nor Laegeforen, 130 (22), 2223
    PubMed 21109841
29. Trøseid M, Johannessen A (2010)
    [The battle against HIV can be won, but there is not enough money!]
    Tidsskr Nor Laegeforen, 130 (16), 1599-600
    PubMed 20805855
30. Trøseid M, Nowak P, Nyström J, Lindkvist A, Abdurahman S, Sönnerborg A (2010)
    Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy
    AIDS, 24 (11), 1733-7
    PubMed 20502315
31. Weiss TW, Schumacher S, Kaun C, Katsaros KM, Trøseid M, Huber K, Maurer G, Wojta J (2010)
    Association between smoking and presence of mycoplasma pneumoniae in circulating leukocytes
    Swiss Med Wkly, 140, w13105
    PubMed 20927683

Publications 2009

1. Baekken M, Os I, Stenehjem A, Sandvik L, Oektedalen O (2009)
   Association between HIV infection and attenuated diurnal blood pressure rhythm in untreated hypertensive individuals
   HIV Med, 10 (1), 44-52
   PubMed 19018875
2. Berhe N, Myrvang B, Gundersen SG (2009)
   Gastro-intestinal symptoms associated with intense Schistosoma mansoni infection affect class-attentiveness of schoolchildren in Ethiopia
   Acta Trop, 110 (1), 52-6
   PubMed 19283896
3. Brantsaeter AB (2009)
   [An underestimated throat bacteria]
   Tidsskr Nor Laegeforen, 129 (17), 1756
   PubMed 19756058
4. Brantsaeter AB, Romanus V, Andersen PH, Heldal E (2009)
   Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries
   Int J Tuberc Lung Dis, 13 (4), 440-5
   PubMed 19335948
5. Chaplin JE, Hanas R, Lind A, Tollig H, Wramner N, Lindblad B (2009)
   Assessment of childhood diabetes-related quality-of-life in West Sweden
   Acta Paediatr, 98 (2), 361-6
   PubMed 18976373
6. Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte A, Katlama C, Eg Hansen AB, Horban A, Bruun J, Clotet B, Lundgren JD, EuroSIDA Study Group (2009)
   Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings
   J Infect Dis, 200 (5), 687-97
   PubMed 19604043
7. Dalgard O, Mangia A (2009)
   Management of patients with hepatitis C virus genotype 2 or 3: comments on updated American Association for the Study of Liver Diseases practice guidelines
   Hepatology, 50 (1), 323; author reply 324-5
   PubMed 19554545
8. Damås JK, Davì G, Jensenius M, Santilli F, Otterdal K, Ueland T, Flo TH, Lien E, Espevik T, Frøland SS, Vitale G, Raoult D, Aukrust P (2009)
   Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever
   J Infect, 58 (1), 68-75
   PubMed 19091423
9. Ellertsen LK, Storla DG, Diep LM, Brokstad KA, Wiker HG, Hetland G (2009)
   Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy
   BMC Infect Dis, 9, 100
   PubMed 19558655
10. Gautret P, Clerinx J, Caumes E, Simon F, Jensenius M, Loutan L, Schlagenhauf P, Castelli F, Freedman D, Miller A, Bronner U, Parola P (2009)
    Imported human African trypanosomiasis in Europe, 2005-2009
    Euro Surveill, 14 (36)
    PubMed 19758542
11. Hauge SH, Dudman SG, Borgen K, Hungnes O, Brantsaeter A, Iversen B, Aavitsland P (2009)
    [Disease caused by the new influenza A(H1N1) virus]
    Tidsskr Nor Laegeforen, 129 (17), 1736-9
    PubMed 19756053
12. Hotez PJ, Fenwick A, Kjetland EF (2009)
    Africa's 32 cents solution for HIV/AIDS
    PLoS Negl Trop Dis, 3 (5), e430
    PubMed 19479041
13. Jensenius M, Davis X, von Sonnenburg F, Schwartz E, Keystone JS, Leder K, Lopéz-Véléz R, Caumes E, Cramer JP, Chen L, Parola P, GeoSentinel Surveillance Network (2009)
    Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008
    Emerg Infect Dis, 15 (11), 1791-8
    PubMed 19891867
14. Johannessen A, Garrido C, Zahonero N, Sandvik L, Naman E, Kivuyo SL, Kasubi MJ, Gundersen SG, Bruun JN, de Mendoza C (2009)
    Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania
    Clin Infect Dis, 49 (6), 976-81
    PubMed 19663598
15. Johannessen A, Naman E, Kivuyo SL, Kasubi MJ, Holberg-Petersen M, Matee MI, Gundersen SG, Bruun JN (2009)
    Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania
    BMC Infect Dis, 9, 108
    PubMed 19583845
16. Johannessen A, Trøseid M, Calmy A (2009)
    Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings
    J Antimicrob Chemother, 64 (6), 1126-9
    PubMed 19776036
17. Kjetland EF, Hove RJ, Gomo E, Midzi N, Gwanzura L, Mason P, Friis H, Verweij JJ, Gundersen SG, Ndhlovu PD, Mduluza T, Van Lieshout L (2009)
    Schistosomiasis PCR in vaginal lavage as an indicator of genital Schistosoma haematobium infection in rural Zimbabwean women
    Am J Trop Med Hyg, 81 (6), 1050-5
    PubMed 19996436
18. Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
    Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
    J Clin Microbiol, 47 (7), 2170-4
    PubMed 19420166
19. Magnus P, Brubakk O, Nyland H, Wold BH, Gjessing HK, Brandt I, Eidem T, Nøkleby H, Stene-Larsen G (2009)
    Vaccination as teenagers against meningococcal disease and the risk of the chronic fatigue syndrome
    Vaccine, 27 (1), 23-7
    PubMed 18984023
20. Maagaard A, Kvale D (2009)
    Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
    J Antimicrob Chemother, 64 (5), 901-9
    PubMed 19740910
21. Maagaard A, Kvale D (2009)
    Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity
    Scand J Infect Dis, 41 (11-12), 808-17
    PubMed 19922062
22. Newport MJ, Myrvang B (2009)
    Proceedings of a joint meeting between the Norwegian Society of Infectious Diseases and the Royal Society of Tropical Medicine and Hygiene, Oslo, 20 June 2008
    Trans R Soc Trop Med Hyg, 103 (4), 321-4
    PubMed 19111872
23. Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O (2009)
    Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania
    BMC Infect Dis, 9, 1
    PubMed 19144106
24. Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A, de Mendoza C, Derdelinckx I, Grossman Z, Hamouda O, Hoepelman I, Horban A, Korn K, Kücherer C, Leitner T et al. (2009)
    Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
    Retrovirology, 6, 49
    PubMed 19457244
25. Sandanger Ø, Ryan L, Bohnhorst J, Iversen AC, Husebye H, Halaas Ø, Landrø L, Aukrust P, Frøland SS, Elson G, Visintin A, Øktedalen O, Damås JK, Sundan A, Golenbock D, Espevik T (2009)
    IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients
    J Immunol, 182 (1), 588-95
    PubMed 19109192
26. Torheim EA, Ndhlovu LC, Pettersen FO, Larsen TL, Jha AR, Torgersen KM, Kvale D, Nixon DF, Taskén K, Aandahl EM (2009)
    Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population
    Eur J Immunol, 39 (5), 1280-7
    PubMed 19384871
27. Trøseid M, Eskesen A, Bruun JN (2009)
    [Immune reconstitution inflammatory syndrome and treatment of HIV infection]
    Tidsskr Nor Laegeforen, 129 (23), 2484-7
    PubMed 19997137

Publications 2008

1. Baba K, Dyrhol-Riise AM, Sviland L, Langeland N, Hoosen AA, Wiker HG, Mustafa T (2008)
   Rapid and specific diagnosis of tuberculous pleuritis with immunohistochemistry by detecting Mycobacterium tuberculosis complex specific antigen MPT64 in patients from a HIV endemic area
   Appl Immunohistochem Mol Morphol, 16 (6), 554-61
   PubMed 18698260
2. Baba K, Hoosen AA, Langeland N, Dyrhol-Riise AM (2008)
   Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts
   PLoS One, 3 (7), e2788
   PubMed 18665218
3. Baba K, Pathak S, Sviland L, Langeland N, Hoosen AA, Asjo B, Dyrhol-Riise AM, Mustafa T (2008)
   Real-time quantitative PCR in the diagnosis of tuberculosis in formalin-fixed paraffin-embedded pleural tissue in patients from a high HIV endemic area
   Diagn Mol Pathol, 17 (2), 112-7
   PubMed 18382372
4. Baba K, Sørnes S, Hoosen AA, Lekabe JM, Mpe MJ, Langeland N, Dyrhol-Riise AM (2008)
   Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-gamma assay
   BMC Infect Dis, 8, 35
   PubMed 18366633
5. Baekken M, Os I, Sandvik L, Oektedalen O (2008)
   Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy
   J Hypertens, 26 (11), 2126-33
   PubMed 18854751
6. Baekken M, Os I, Sandvik L, Oektedalen O (2008)
   Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population
   Nephrol Dial Transplant, 23 (10), 3130-7
   PubMed 18469311
7. Berhe N, Myrvang B, Gundersen SG (2008)
   Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia
   Am J Trop Med Hyg, 78 (2), 228-34
   PubMed 18256420
8. Berild D, Abrahamsen TG, Andresen S, Bjørløw E, Haug O, Kossenko IM, Kubar OI, Lelek M, Mintchenko SI, Pyasetskaya MF, Ringertz SH, Sysenko GA (2008)
   A controlled intervention study to improve antibiotic use in a Russian paediatric hospital
   Int J Antimicrob Agents, 31 (5), 478-83
   PubMed 18343641
9. Berild D, Haug JB (2008)
   [Rational use of antibiotics in hospitals]
   Tidsskr Nor Laegeforen, 128 (20), 2335-9
   PubMed 19096490
10. Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K, CASCADE Collaboration (2008)
    Changes in the risk of death after HIV seroconversion compared with mortality in the general population
    JAMA, 300 (1), 51-9
    PubMed 18594040
11. Bjark P, Ormaasen V, Skjelmerud T (2008)
    [Treatment of erythema migrans]
    Tidsskr Nor Laegeforen, 128 (24), 2844
    PubMed 19092956
12. Brantsaeter AB (2008)
    [Action against tuberculosis--all has its time]
    Tidsskr Nor Laegeforen, 128 (24), 2817
    PubMed 19092946
13. Cazorla C, Socolovschi C, Jensenius M, Parola P (2008)
    Tick-borne diseases: tick-borne spotted fever rickettsioses in Africa
    Infect Dis Clin North Am, 22 (3), 531-44, ix-x
    PubMed 18755389
14. Dalgard O, Bjøro K, Ring-Larsen H, Bjornsson E, Holberg-Petersen M, Skovlund E, Reichard O, Myrvang B, Sundelöf B, Ritland S, Hellum K, Frydén A, Florholmen J, Verbaan H, North-C Group (2008)
    Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
    Hepatology, 47 (1), 35-42
    PubMed 17975791
15. Eliassen KE, Fetveit A, Hjortdahl P, Berild D, Lindbaek M (2008)
    [New guidelines for antibiotic use in primary health care]
    Tidsskr Nor Laegeforen, 128 (20), 2330-4
    PubMed 19096489
16. Eliassen KE, Lindbaek M, Berild D, Hjortdahl P, Fetveit A (2008)
    [First-choice treatment for erythema migrans is still penicillin]
    Tidsskr Nor Laegeforen, 128 (15), 1681; author reply 1681
    PubMed 18704139
17. Haldorsen IS, Kråkenes J, Goplen AK, Dunlop O, Mella O, Espeland A (2008)
    AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003
    BMC Cancer, 8, 225
    PubMed 18684320
18. Holm M, Pettersen FO, Kvale D (2008)
    PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples
    Curr HIV Res, 6 (1), 49-58
    PubMed 18288975
19. Jelinek T, Schade Larsen C, Siikamäki H, Myrvang B, Chiodini P, Gascon J, Visser L, Kapaun A, Just-Nübling G (2008)
    European cluster of imported falciparum malaria from Gambia
    Euro Surveill, 13 (51)
    PubMed 19094917
20. Jensenius M, Maeland A, Brubakk O (2008)
    Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics
    Travel Med Infect Dis, 6 (1-2), 45-7
    PubMed 18342274
21. Jensenius M, von der Lippe B, Hermansen NO, Jahr G, Caugant DA, Høiby EA, Vene S (2008)
    Brucellar mastitis: presentation of a case and review of the literature
    Int J Infect Dis, 12 (1), 98-100
    PubMed 17537662
22. Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, Gundersen SG, Bruun JN (2008)
    Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania
    BMC Infect Dis, 8, 52
    PubMed 18430196
23. Josephson F, Bertilsson L, Böttiger Y, Flamholc L, Gisslén M, Ormaasen V, Sönnerborg A, Diczfalusy U (2008)
    CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels
    Eur J Clin Pharmacol, 64 (8), 775-81
    PubMed 18458892
24. Jourdan PM, Laoussou P, Lybie A, Kjetland EF (2008)
    Indicators of anaemia in under-fives with malaria at a hospital in northern Cameroon
    West Afr J Med, 27 (1), 7-12
    PubMed 18689296
25. Kjetland EF, Kurewa EN, Ndhlovu PD, Midzi N, Gwanzura L, Mason PR, Gomo E, Sandvik L, Mduluza T, Friis H, Gundersen SG (2008)
    Female genital schistosomiasis--a differential diagnosis to sexually transmitted disease: genital itch and vaginal discharge as indicators of genital Schistosoma haematobium morbidity in a cross-sectional study in endemic rural Zimbabwe
    Trop Med Int Health, 13 (12), 1509-17
    PubMed 19055625
26. Kjetland EF, Ndhlovu PD, Kurewa EN, Midzi N, Gomo E, Mduluza T, Friis H, Gundersen SG (2008)
    Prevention of gynecologic contact bleeding and genital sandy patches by childhood anti-schistosomal treatment
    Am J Trop Med Hyg, 79 (1), 79-83
    PubMed 18606767
27. Mørch K, Strand Ø, Dunlop O, Berg A, Langeland N, Leiva RA, Longva JA, Sjursen H, Skrede S, Sundal J, Jensenius M (2008)
    Severe malaria and artesunate treatment, Norway
    Emerg Infect Dis, 14 (11), 1816-8
    PubMed 18976584
28. Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D (2008)
    Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment
    J Infect Dis, 198 (10), 1474-81
    PubMed 18851688
29. Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O (2008)
    Pulmonary tuberculosis among people living with HIV/AIDS attending care and treatment in rural northern Tanzania
    BMC Public Health, 8, 341
    PubMed 18826574

Publications 2007

1. Behrens RH, Carroll B, Beran J, Bouchaud O, Hellgren U, Hatz C, Jelinek T, Legros F, Mühlberger N, Myrvang B, Siikamäki H, Visser L, TropNetEurop (2007)
   The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?
   Malar J, 6, 114
   PubMed 17716367
2. Berhe N, Halvorsen BL, Gundersen TE, Myrvang B, Gundersen SG, Blomhoff R (2007)
   Reduced serum concentrations of retinol and alpha-tocopherol and high concentrations of hydroperoxides are associated with community levels of S. mansoni infection and schistosomal periportal fibrosis in Ethiopian school children
   Am J Trop Med Hyg, 76 (5), 943-9
   PubMed 17488920
3. Berhe N, Myrvang B, Gundersen SG (2007)
   Intensity of Schistosoma mansoni, hepatitis B, age, and sex predict levels of hepatic periportal thickening/fibrosis (PPT/F): a large-scale community-based study in Ethiopia
   Am J Trop Med Hyg, 77 (6), 1079-86
   PubMed 18165526
4. Brantsaeter AB, Holberg-Petersen M, Jeansson S, Goplen AK, Bruun JN (2007)
   CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection - a retrospective autopsy based study
   BMC Infect Dis, 7, 127
   PubMed 17986346
5. Brubakk O, Bjørneklett A, Sjursen H, Viggen B (2007)
   [Use of a new antibiotic in Norway]
   Tidsskr Nor Laegeforen, 127 (15), 1931-2
   PubMed 17700733
6. Bugge H, Negaard A, Skeie L, Bergersen B (2007)
   Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients
   HIV Med, 8 (8), 475-82
   PubMed 17944679
7. Haukeland JW, Lorgen I, Schreiner LT, Frigstad SO, Brandsaeter B, Bjøro K, Bang C, Raknerud N, Konopski Z (2007)
   Incidence rates and causes of cirrhosis in a Norwegian population
   Scand J Gastroenterol, 42 (12), 1501-8
   PubMed 17852839
8. Jensenius M, Berild D, Ormaasen V, Maehlen J, Lindegren G, Falk KI (2007)
   Fatal subarachnoidal haemorrhage in a Norwegian traveller with dengue virus infection
   Scand J Infect Dis, 39 (3), 272-4
   PubMed 17366065
9. Krook AL, Stokka D, Heger B, Nygaard E (2007)
   Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study
   Eur Addict Res, 13 (4), 216-21
   PubMed 17851243
10. Mengistu Z, Engh V, Melby KK, von der Lippe E, Qvigstad E (2007)
    Postmenopausal vaginal bleeding caused by endometrial tuberculosis
    Acta Obstet Gynecol Scand, 86 (5), 631-2
    PubMed 17464596
11. Maagaard A, Holberg-Petersen M, Torjesen PA, Bruun JN, Kvale D (2007)
    Insulin resistance is affected by increased levels of plasma lactate but not mitochondrial alterations in skeletal muscle in NRTI-exposed HIV-infected patients
    HIV Clin Trials, 8 (5), 345-53
    PubMed 17956836
12. Ndhlovu PD, Mduluza T, Kjetland EF, Midzi N, Nyanga L, Gundersen SG, Friis H, Gomo E (2007)
    Prevalence of urinary schistosomiasis and HIV in females living in a rural community of Zimbabwe: does age matter?
    Trans R Soc Trop Med Hyg, 101 (5), 433-8
    PubMed 17064746
13. Ormaasen V, Sandvik L, Dudman SG, Bruun JN (2007)
    HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population
    Scand J Infect Dis, 39 (1), 51-7
    PubMed 17366013
14. Storla DG, Rahim Z, Islam MA, Plettner S, Begum V, Myrvang B, Bjune G, Rønnild E, Dahle UR, Mannsåker T (2007)
    Drug resistance of Mycobacterium tuberculosis in the Sunamganj District of Bangladesh
    Scand J Infect Dis, 39 (2), 142-5
    PubMed 17366031
15. Zuckerman J, van Hattum J, Cafferkey M, Gjørup I, Hoel T, Rummukainen ML, Weiland O (2007)
    Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?
    Lancet Infect Dis, 7 (6), 410-9
    PubMed 17521594

Publications 2006

1. Bergersen BM (2006)
   Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy
   Drugs, 66 (15), 1971-87
   PubMed 17100407
2. Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K (2006)
   Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls
   Scand J Infect Dis, 38 (8), 682-9
   PubMed 16857615
3. Berhe N, Geitung JT, Medhin G, Gundersen SG (2006)
   Large scale evaluation of WHO's ultrasonographic staging system of schistosomal periportal fibrosis in Ethiopia
   Trop Med Int Health, 11 (8), 1286-94
   PubMed 16903891
4. Berild D, Mohseni A, Diep LM, Jensenius M, Ringertz SH (2006)
   Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs
   J Antimicrob Chemother, 57 (2), 326-30
   PubMed 16387751
5. Brantsaeter AB (2006)
   [Tularemia]
   Tidsskr Nor Laegeforen, 126 (8), 1034
   PubMed 16619059
6. Bruun JN, Skeie L, Maeland A, Dudman SG, Sannes M, Ormaasen V (2006)
   [HIV/AIDS--from lethal syndrome to chronic disease]
   Tidsskr Nor Laegeforen, 126 (23), 3121-4
   PubMed 17160119
7. Damås JK, Jensenius M, Ueland T, Otterdal K, Yndestad A, Frøland SS, Rolain JM, Myrvang B, Raoult D, Aukrust P (2006)
   Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets
   J Immunol, 177 (4), 2699-706
   PubMed 16888032
8. Gjeruldsen S, Loge JH, Myrvang B, Opjordsmoen S (2006)
   Drug addiction in hepatitis C patients leads to a lower quality of life
   Nord J Psychiatry, 60 (2), 157-61
   PubMed 16635936
9. Jensenius M, Fournier PE, Fladby T, Hellum KB, Hagen T, Priø T, Christiansen MS, Vene S, Raoult D, Myrvang B (2006)
   Sub-acute neuropathy in patients with African tick bite fever
   Scand J Infect Dis, 38 (2), 114-8
   PubMed 16449002
10. Jensenius M, Montelius R, Berild D, Vene S (2006)
    Scrub typhus imported to Scandinavia
    Scand J Infect Dis, 38 (3), 200-2
    PubMed 16500780
11. Johannessen A (2006)
    [Buruli ulcer emerging from obscurity]
    Tidsskr Nor Laegeforen, 126 (16), 2148
    PubMed 16967521
12. Kjetland EF, Mduluza T, Ndhlovu PD, Gomo E, Gwanzura L, Midzi N, Mason PR, Friis H, Gundersen SG (2006)
    Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel
    Trans R Soc Trop Med Hyg, 100 (8), 740-52
    PubMed 16406034
13. Kjetland EF, Ndhlovu PD, Gomo E, Mduluza T, Midzi N, Gwanzura L, Mason PR, Sandvik L, Friis H, Gundersen SG (2006)
    Association between genital schistosomiasis and HIV in rural Zimbabwean women
    AIDS, 20 (4), 593-600
    PubMed 16470124
14. Kran AM, Kvale D (2006)
    [Immunopathogenesis and therapeutic immunization in HIV-infection]
    Tidsskr Nor Laegeforen, 126 (23), 3112-6
    PubMed 17160117
15. Kran AM, Sørensen B, Sommerfelt MA, Nyhus J, Baksaas I, Kvale D (2006)
    Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells
    AIDS, 20 (4), 627-30
    PubMed 16470131
16. Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K (2006)
    Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
    AIDS, 20 (6), 813-20
    PubMed 16549964
17. Moghaddam A, Reinton N, Dalgard O (2006)
    A rapid real-time PCR assay for determination of hepatitis C virus genotypes 1, 2 and 3a
    J Viral Hepat, 13 (4), 222-9
    PubMed 16611187
18. Maagaard A, Holberg-Petersen M, Kollberg G, Oldfors A, Sandvik L, Bruun JN (2006)
    Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients
    Antivir Ther, 11 (5), 601-8
    PubMed 16964828
19. Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN (2006)
    Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients
    HIV Med, 7 (1), 53-8
    PubMed 16313293
20. Nygård K, Brantsaeter A, Feruglio S, Ravn J, Dotevall L, Hasle G, Myrvang B (2006)
    [Histoplasmosis among travellers to Central America]
    Tidsskr Nor Laegeforen, 126 (21), 2838-42
    PubMed 17086244
21. Nyhus J, Kran AM, Sommerfelt MA, Baksaas I, Sørensen B, Kvale D (2006)
    Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
    Vaccine, 24 (10), 1543-50
    PubMed 16289707
22. Ormaasen V, Sandvik L, Rudberg N, Bruun JN (2006)
    Serum concentrations of protease inhibitors as predictors of HIV-related clinical events in patients on antiretroviral therapy
    Scand J Infect Dis, 38 (8), 650-3
    PubMed 16857610
23. Skeie L, Maeland A (2006)
    Can efavirenz be taken in the morning?
    Scand J Infect Dis, 38 (11-12), 1089-91
    PubMed 17148083
24. Storla DG, Rahim Z, Islam MA, Plettner S, Begum V, Mannsaaker T, Myrvang B, Bjune G, Dahle UR (2006)
    Heterogeneity of Mycobacterium tuberculosis isolates in Sunamganj District, Bangladesh
    Scand J Infect Dis, 38 (8), 593-6
    PubMed 16857601
25. van de Vijver DA, Wensing AM, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L et al. (2006)
    The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
    J Acquir Immune Defic Syndr, 41 (3), 352-60
    PubMed 16540937
26. Voltersvik P, Bostad L, Dyrhol-Riise AM, Eide GE, Røsok BI, Olofsson J, Asjö B (2006)
    Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy
    J Acquir Immune Defic Syndr, 41 (3), 277-84
    PubMed 16540928
27. von der Lippe B, Sandven P, Brubakk O (2006)
    Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases
    J Infect, 52 (2), 92-6
    PubMed 15907341
28. Wiker HG, Mustafa T, Målen H, Riise AM (2006)
    Vaccine approaches to prevent tuberculosis
    Scand J Immunol, 64 (3), 243-50
    PubMed 16918693

Publications 2005

1. Abrahamsen IW, Sømme S, Heldal D, Egeland T, Kvale D, Tjønnfjord GE (2005)
   Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease
   Haematologica, 90 (1), 86-93
   PubMed 15642674
2. Bergersen BM, Sandvik L, Ellingsen I, Bruun JN (2005)
   Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive
   HIV Med, 6 (4), 260-7
   PubMed 16011531
3. Bergersen BM, Tonstad S, Sandvik L, Bruun JN (2005)
   Low prevalence of high-density lipoprotein cholesterol level < 1 mmol/L in non-nucleoside reverse transcriptase inhibitor recipients
   Int. J. STD AIDS, 16 (5), 365-369
4. Bergersen BM, Tonstad S, Sandvik L, Bruun JN (2005)
   Low prevalence of high-density lipoprotein cholesterol level < 1 mmol/L in non-nucleoside reverse transcriptase inhibitor recipients
   Int J STD AIDS, 16 (5), 365-9
   PubMed 15949067
5. Blystad H, Brantsaeter AB, Lovoll Ø (2005)
   Outbreak of community-acquired legionnaires disease in southeast Norway, May 2005
   Euro Surveill, 10 (5), E050526.1
   PubMed 16770016
6. Farah MG, Tverdal A, Steen TW, Heldal E, Brantsaeter AB, Bjune G (2005)
   Treatment outcome of new culture positive pulmonary tuberculosis in Norway
   BMC Public Health, 5, 14
   PubMed 15698472
7. Jensenius M, Flaegstad T, Stenstad T, Gjølberg T, Vlatkovic L, Schjøth-Iversen L, Berild D, Bordmann G, Myrvang B (2005)
   Fascioliasis imported to Norway
   Scand J Infect Dis, 37 (6-7), 534-7
   PubMed 16012024
8. Jensenius M, Pretorius AM, Clarke F, Myrvang B (2005)
   Repellent efficacy of four commercial DEET lotions against Amblyomma hebraeum (Acari: Ixodidae), the principal vector of Rickettsia africae in southern Africa
   Trans R Soc Trop Med Hyg, 99 (9), 708-11
   PubMed 15993907
9. Kjetland EF, Gwanzura L, Ndhlovu PD, Mduluza T, Gomo E, Mason PR, Midzi N, Friis H, Gundersen SG (2005)
   Herpes simplex virus type 2 prevalence of epidemic proportions in rural Zimbabwean women: association with other sexually transmitted infections
   Arch Gynecol Obstet, 272 (1), 67-73
   PubMed 15647913
10. Kjetland EF, Ndhlovu PD, Mduluza T, Gomo E, Gwanzura L, Mason PR, Kurewa EN, Midzi N, Friis H, Gundersen SG (2005)
    Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women
    Am J Trop Med Hyg, 72 (3), 311-9
    PubMed 15772328
11. Kran AM, Sommerfelt MA, Sørensen B, Nyhus J, Baksaas I, Bruun JN, Kvale D (2005)
    Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization
    Vaccine, 23 (31), 4011-5
    PubMed 15963359
12. Kvale D, Kran AM, Sommerfelt MA, Nyhus J, Baksaas I, Bruun JN, Sørensen B (2005)
    Divergent in vitro and in vivo correlates of HIV-specific T-cell responses during onset of HIV viraemia
    AIDS, 19 (6), 563-7
    PubMed 15802974
13. Nygård K, Brantsaeter AB, Mehl R (2005)
    Disseminated and chronic Lyme borreliosis in Norway, 1995 - 2004
    Euro Surveill, 10 (10), 235-8
    PubMed 16282646
14. Wensing AM, van de Vijver DA, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L et al. (2005)
    Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
    J Infect Dis, 192 (6), 958-66
    PubMed 16107947

Publications 2004

1. Bergersen BM, Sandvik L, Bruun JN (2004)
   Body composition changes in 308 Norwegian HIV-positive patients
   Scand J Infect Dis, 36 (3), 186-91
   PubMed 15119363
2. Bergersen BM, Sandvik L, Bruun JN, Tonstad S (2004)
   Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects
   Eur J Clin Microbiol Infect Dis, 23 (8), 625-30
   PubMed 15322938
3. Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoërsdorff A, Blanco JR, Caruso G, Cinco M, Fournier PE, Francavilla E, Jensenius M, Kazar J, Laferl H, Lakos A, Lotric Furlan S, Maurin M, Oteo JA, Parola P, Perez-Eid C, Peter O, Postic D, Raoult D, Tellez A, Tselentis Y, Wilske B et al. (2004)
   Guidelines for the diagnosis of tick-borne bacterial diseases in Europe
   Clin Microbiol Infect, 10 (12), 1108-32
   PubMed 15606643
4. Brubakk O (2004)
   [Penicillins and other beta-lactam antibiotics]
   Tidsskr Nor Laegeforen, 124 (23), 3077
   PubMed 15593450
5. Brubakk O, Bruun JN (2004)
   [When should macrolides be used in upper respiratory tract infections?]
   Tidsskr Nor Laegeforen, 124 (4), 495-6
   PubMed 14983197
6. Baay MF, Kjetland EF, Ndhlovu PD, Deschoolmeester V, Mduluza T, Gomo E, Friis H, Midzi N, Gwanzura L, Mason PR, Vermorken JB, Gundersen SG (2004)
   Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution
   J Med Virol, 73 (3), 481-5
   PubMed 15170646
7. Dalgard O, Bjøro K, Hellum KB, Myrvang B, Ritland S, Skaug K, Raknerud N, Bell H (2004)
   Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study
   Hepatology, 40 (6), 1260-5
   PubMed 15558712
8. Jelinek T, Myrvang B (2004)
   Surveillance of imported infectious diseases in Europe: report from the 4th TropNetEurop workshop
   Acta Trop, 91 (1), 47-51
   PubMed 15158688
9. Jensenius M, Fournier PE, Raoult D (2004)
   Tick-borne rickettsioses in international travellers
   Int J Infect Dis, 8 (3), 139-46
   PubMed 15109588
10. Jensenius M, Fournier PE, Raoult D (2004)
    Rickettsioses and the international traveler
    Clin Infect Dis, 39 (10), 1493-9
    PubMed 15546086
11. Jensenius M, Fournier PE, Vene S, Ringertz SH, Myrvang B, Raoult D (2004)
    Comparison of immunofluorescence, Western blotting, and cross-adsorption assays for diagnosis of African tick bite fever
    Clin Diagn Lab Immunol, 11 (4), 786-8
    PubMed 15242958
12. Kran AM, Sørensen B, Nyhus J, Sommerfelt MA, Baksaas I, Bruun JN, Kvale D (2004)
    HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
    AIDS, 18 (14), 1875-83
    PubMed 15353973
13. Lugada ES, Mermin J, Asjo B, Kaharuza F, Downing R, Langeland N, Ormaasen V, Bruun J, Awor AC, Ulvestad E (2004)
    Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway
    Scand J Immunol, 59 (2), 203-8
    PubMed 14871298
14. Mühlberger N, Jelinek T, Gascon J, Probst M, Zoller T, Schunk M, Beran J, Gjørup I, Behrens RH, Clerinx J, Björkman A, McWhinney P, Matteelli A, Lopez-Velez R, Bisoffi Z, Hellgren U, Puente S, Schmid ML, Myrvang B, Holthoff-Stich ML, Laferl H, Hatz C, Kollaritsch H, Kapaun A, Knobloch J et al. (2004)
    Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop
    Malar J, 3, 5
    PubMed 15003128
15. Nilssen DE, Øktedalen O, Brandtzaeg P (2004)
    Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy
    Gut, 53 (4), 487-93
    PubMed 15016741
16. Ormaasen V, Sandvik L, Asjø B, Holberg-Petersen M, Gaarder PI, Bruun JN (2004)
    An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy
    HIV Med, 5 (6), 400-6
    PubMed 15544691
17. Pretorius AM, Jensenius M, Birtles RJ (2004)
    Update on spotted fever group Rickettsiae in South Africa
    Vector Borne Zoonotic Dis, 4 (3), 249-60
    PubMed 15631070
18. Rogne Gjeruldsen S, Myrvang B, Opjordsmoen S (2004)
    Criminality in drug addicts: a follow-up study over 25 years
    Eur Addict Res, 10 (2), 49-55
    PubMed 15004447
19. Rolain JM, Jensenius M, Raoult D (2004)
    Rickettsial infections--a threat to travellers?
    Curr Opin Infect Dis, 17 (5), 433-7
    PubMed 15353963
20. Simonsen GS, Berdal JE, Sundsfjord A, Berild D (2004)
    [Simplified and not exact about antibiotics]
    Tidsskr Nor Laegeforen, 124 (18), 2397; author reply 2397-8
    PubMed 15467814

Publications 2003

1. Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN (2003)
   Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients
   Eur J Clin Microbiol Infect Dis, 22 (12), 731-6
   PubMed 14610658
2. Berild D, Smaabrekke L, Halvorsen DS, Lelek M, Stahlsberg EM, Ringertz SH (2003)
   Clostridium difficile infections related to antibiotic use and infection control facilities in two university hospitals
   J Hosp Infect, 54 (3), 202-6
   PubMed 12855235
3. Cozzi-Lepri A, Phillips AN, Miller V, Katlama C, Ledergerber B, Vella S, Weber J, Bruun JN, Kirk O, Clotet B, Lundgrens JD (2003)
   Changes in viral load in people with virological failure who remain on the same HAART regimen
   Antivir Ther, 8 (2), 127-36
   PubMed 12741625
4. Gjeruldsen S, Myrvang B, Opjordsmoen S (2003)
   Risk factors for drug addiction and its outcome. A follow-up study over 25 years
   Nord J Psychiatry, 57 (5), 373-6
   PubMed 14522611
5. Gjeruldsen SR, Myrvang B, Opjordsmoen S (2003)
   A 25-year follow-up study of drug addicts hospitalised for acute hepatitis: present and past morbidity
   Eur Addict Res, 9 (2), 80-6
   PubMed 12644734
6. Grobusch MP, Mühlberger N, Jelinek T, Bisoffi Z, Corachán M, Harms G, Matteelli A, Fry G, Hatz C, Gjørup I, Schmid ML, Knobloch J, Puente S, Bronner U, Kapaun A, Clerinx J, Nielsen LN, Fleischer K, Beran J, da Cunha S, Schulze M, Myrvang B, Hellgren U (2003)
   Imported schistosomiasis in Europe: sentinel surveillance data from TropNetEurop
   J Travel Med, 10 (3), 164-9
   PubMed 12757691
7. Jensenius M, Fournier PE, Hellum KB, Wesslén L, Caruso G, Priø T, Løhne K, Vene S, Raoult D, Myrvang B (2003)
   Sequential changes in hematologic and biochemical parameters in African tick bite fever
   Clin Microbiol Infect, 9 (7), 678-83
   PubMed 12925109
8. Jensenius M, Fournier PE, Kelly P, Myrvang B, Raoult D (2003)
   African tick bite fever
   Lancet Infect Dis, 3 (9), 557-64
   PubMed 12954562
9. Jensenius M, Fournier PE, Vene S, Hoel T, Hasle G, Henriksen AZ, Hellum KB, Raoult D, Myrvang B, Norwegian African Tick Bite Fever Study Group (2003)
   African tick bite fever in travelers to rural sub-Equatorial Africa
   Clin Infect Dis, 36 (11), 1411-7
   PubMed 12766836
10. Jensenius M, Ueland T, Fournier PE, Brosstad F, Stylianou E, Vene S, Myrvang B, Raoult D, Aukrust P (2003)
    Systemic inflammatory responses in African tick-bite fever
    J Infect Dis, 187 (8), 1332-6
    PubMed 12696016
11. Midzi N, Ndhlovu PD, Nyanga L, Kjetland EF, Reimert CM, Vennervald BJ, Gomo E, Mudenge G, Friis H, Gundersen SG, Mduluza T (2003)
    Assessment of eosinophil cationic protein as a possible diagnostic marker for female genital schistosomiasis in women living in a Schistosoma haematobium endemic area
    Parasite Immunol, 25 (11-12), 581-8
    PubMed 15053779
12. Mühlberger N, Jelinek T, Behrens RH, Gjørup I, Coulaud JP, Clerinx J, Puente S, Burchard G, Gascon J, Grobusch MP, Weitzel T, Zoller T, Kollaritsch H, Beran J, Iversen J, Hatz C, Schmid ML, Björkman A, Fleischer K, Bisoffi Z, Guggemos W, Knobloch J, Matteelli A, Schulze MH, Laferl H et al. (2003)
    Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data
    Clin Infect Dis, 36 (8), 990-5
    PubMed 12684911
13. Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI (2003)
    Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection
    Scand J Infect Dis, 35 (6-7), 383-8
    PubMed 12953949
14. Pretorius AM, Jensenius M, Clarke F, Ringertz SH (2003)
    Repellent efficacy of DEET and KBR 3023 against Amblyomma hebraeum (Acari: Ixodidae)
    J Med Entomol, 40 (2), 245-8
    PubMed 12693855
15. Voltersvik P, Albrektsen G, Ulvestad E, Dyrhol-Riise AM, Sørensen B, Asjö B (2003)
    Changes in immunoglobulin isotypes and immunoglobulin G (IgG) subclasses during highly active antiretroviral therapy: anti-p24 IgG1 closely parallels the biphasic decline in plasma viremia
    J Acquir Immune Defic Syndr, 34 (4), 358-67
    PubMed 14615653

Publications 2002

1. Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, Del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, Lawson-Aye S, Boufassa F, Hamouda O, Fischer K, Pezzotti P, Rezza G, Touloumi G, Hatzakis A, Karafoulidou A, Katsarou O et al. (2002)
   Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks
   Int J Epidemiol, 31 (5), 951-8
   PubMed 12435766
2. Bell H, Dalgard O, Bjøro K, Hellum KB, Myrvang B (2002)
   [Treatment of chronic hepatitis C]
   Tidsskr Nor Laegeforen, 122 (9), 926-8
   PubMed 12082838
3. Berild D, Lindbaek M (2002)
   [Are too many antibiotics prescribed to Norwegian children?]
   Tidsskr Nor Laegeforen, 122 (28), 2690
   PubMed 12523084
4. Berild D, Ringertz SH, Lelek M (2002)
   Appropriate antibiotic use according to diagnoses and bacteriological findings: report of 12 point-prevalence studies on antibiotic use in a university hospital
   Scand J Infect Dis, 34 (1), 56-60
   PubMed 11874166
5. Berild D, Ringertz SH, Aabyholm G, Lelek M, Fosse B (2002)
   Impact of an antibiotic policy on antibiotic use in a paediatric department. Individual based follow-up shows that antibiotics were chosen according to diagnoses and bacterial findings
   Int J Antimicrob Agents, 20 (5), 333-8
   PubMed 12431868
6. Bjøro K, Bell H, Hellum KB, Skaug K, Raknerud N, Sandvei P, Døskeland B, Maeland A, Lund-Tønnesen S, Myrvang B (2002)
   Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study
   Scand J Gastroenterol, 37 (2), 226-32
   PubMed 11843062
7. Bjøro K, Bell H, Myrvang B, Skaug K, Raknerud N, Sandvei P, Størseth S, Ritland S, Lund-Tønnesen S, Bucher A, Hellum KB (2002)
   Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study
   Scand J Gastroenterol, 37 (3), 344-9
   PubMed 11916198
8. Brantsaeter AB, Liestøl K, Goplen AK, Dunlop O, Bruun JN (2002)
   CMV disease in AIDS patients: incidence of CMV disease and relation to survival in a population-based study from Oslo
   Scand J Infect Dis, 34 (1), 50-5
   PubMed 11874165
9. Bruun JN, Maeland A (2002)
   [Mother-to-child transmission of HIV]
   Tidsskr Nor Laegeforen, 122 (11), 1143; author reply 1143
   PubMed 12043061
10. Dalgard O, Bjøro K, Hellum K, Myrvang B, Bjøro T, Haug E, Bell H (2002)
    Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy
    J Intern Med, 251 (5), 400-6
    PubMed 11982739
11. Dalgard O, Bjøro K, Hellum K, Myrvang B, Skaug K, Gutigard B, Bell H, Construct Group (2002)
    Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up
    Eur Addict Res, 8 (1), 45-9
    PubMed 11818693
12. Distante S, Bjøro K, Hellum KB, Myrvang B, Berg JP, Skaug K, Raknerud N, Bell H (2002)
    Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection
    Liver, 22 (3), 269-75
    PubMed 12100578
13. Dunlop O, Bjørklund R, Bruun JN, Evensen R, Goplen AK, Liestøl K, Sannes M, Maehlen J, Myrvang B (2002)
    Early psychomotor slowing predicts the development of HIV dementia and autopsy-verified HIV encephalitis
    Acta Neurol Scand, 105 (4), 270-5
    PubMed 12004769
14. Fournier PE, Jensenius M, Laferl H, Vene S, Raoult D (2002)
    Kinetics of antibody responses in Rickettsia africae and Rickettsia conorii infections
    Clin Diagn Lab Immunol, 9 (2), 324-8
    PubMed 11874871
15. Gjeruldsen S, Myrvang B (2002)
    Hepatitis B virus infection in drug addicts: no acute fatalities, no chronicity and could have benefits
    APMIS, 110 (9), 620-4
    PubMed 12529014
16. Holm AM, Berild D, Ringertz SH, Håheim LL, Høiby EA (2002)
    Occurrence and clinical presentation of systemic pneumococcal infections in an unselected population in Oslo, Norway, between 1993 and 1997
    Eur J Clin Microbiol Infect Dis, 21 (6), 465-7
    PubMed 12111604
17. Jelinek T, Mühlberger N, Harms G, Corachán M, Grobusch MP, Knobloch J, Bronner U, Laferl H, Kapaun A, Bisoffi Z, Clerinx J, Puente S, Fry G, Schulze M, Hellgren U, Gjørup I, Chalupa P, Hatz C, Matteelli A, Schmid M, Nielsen LN, da Cunha S, Atouguia J, Myrvang B, Fleischer K et al. (2002)
    Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop
    Clin Infect Dis, 35 (9), 1047-52
    PubMed 12384837
18. Jensenius M, Hoel T, Raoult D, Fournier PE, Kjelshus H, Bruu AL, Myrvang B (2002)
    Seroepidemiology of Rickettsia africae infection in Norwegian travellers to rural Africa
    Scand J Infect Dis, 34 (2), 93-6
    PubMed 11928860
19. Kvale D, Aaberge IS, Frøland SS (2002)
    Predictive value of immunologic parameters and HIV RNA in relation to humoral pneumococcal polysaccharide vaccine responses in patients with HIV infection
    Eur J Clin Microbiol Infect Dis, 21 (9), 688-90
    PubMed 12373505
20. Leegaard TM, Caugant DA, Frøholm LO, Høiby EA, Rønning EJ, Sandven P, Bruun JN (2002)
    Do HIV-seropositive patients become colonised with drug-resistant microorganisms?
    Eur J Clin Microbiol Infect Dis, 21 (12), 856-63
    PubMed 12525920
21. Miller V, Phillips AN, Clotet B, Mocroft A, Ledergerber B, Kirk O, Ormaasen V, Gargalianos-Kakolyris P, Vella S, Lundgren JD (2002)
    Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts
    J Infect Dis, 186 (2), 189-97
    PubMed 12134254
22. Myrvang B, von der Lippe B (2002)
    [African trypanosomiasis--a rare imported disease]
    Tidsskr Nor Laegeforen, 122 (1), 33-4
    PubMed 11851292
23. Mørch K, Feruglio SL, Ormaasen V, Bruun JN (2002)
    [Severe falciparum malaria treated with exchange transfusion]
    Tidsskr Nor Laegeforen, 122 (10), 999-1001
    PubMed 12082710
24. Maagaard A, Oktedalen O (2002)
    Psoas abscess diagnosed at a Northern university hospital
    Scand J Infect Dis, 34 (11), 848-51
    PubMed 12578159
25. Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI (2002)
    A search for optimal criteria in initiating antiretroviral therapy in chronic human immunodeficiency virus infection focusing on CD4 count and HIV RNA
    Scand J Infect Dis, 34 (12), 910-7
    PubMed 12587624
26. Rollag H, Sagedal S, Kristiansen KI, Kvale D, Holter E, Degré M, Nordal KP (2002)
    Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
    Clin Microbiol Infect, 8 (7), 431-4
    PubMed 12199854
27. Småbrekke L, Berild D, Giaever A, Myrbakk T, Fuskevåg A, Ericson JU, Flaegstad T, Olsvik O, Ringertz SH (2002)
    Educational intervention for parents and healthcare providers leads to reduced antibiotic use in acute otitis media
    Scand J Infect Dis, 34 (9), 657-9
    PubMed 12374355
28. Strand EA, Strand ØA, Hellum KB, Smith-Erichsen N, Myrvang B (2002)
    [A young, stuporous and afebrile man with icterus and nosebleed]
    Tidsskr Nor Laegeforen, 122 (6), 619-23
    PubMed 11998715
29. Tobiassen T, Berild D, Hjortdahl P (2002)
    [Use of systemic antibiotics in a Norwegian nursing home]
    Tidsskr Nor Laegeforen, 122 (24), 2376-8
    PubMed 12448254
30. von der Lippe E (2002)
    [Dosage of antibiotics in patients with reduced renal function]
    Tidsskr Nor Laegeforen, 122 (25), 2461-3
    PubMed 12448117

Publications 2001

1. Berild D, Ringertz SH, Lelek M, Fosse B (2001)
   Antibiotic guidelines lead to reductions in the use and cost of antibiotics in a university hospital
   Scand J Infect Dis, 33 (1), 63-7
   PubMed 11234982
2. Bruun JN (2001)
   [Import of resistant bacteria]
   Tidsskr Nor Laegeforen, 121 (2), 156
   PubMed 11475187
3. Dyrhol-Riise AM, Ohlsson M, Skarstein K, Nygaard SJ, Olofsson J, Jonsson R, Asjö B (2001)
   T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy
   Clin Immunol, 101 (2), 180-91
   PubMed 11683577
4. Dyrhol-Riise AM, Stent G, Røsok BI, Voltersvik P, Olofsson J, Asjö B (2001)
   The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy
   Clin Immunol, 101 (2), 169-79
   PubMed 11683576
5. Dyrhol-Riise AM, Voltersvik P, Berg OG, Olofsson J, Kleivbo S, Asjö B (2001)
   Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization
   AIDS Res Hum Retroviruses, 17 (7), 577-86
   PubMed 11375053
6. Fylkesnes SI, Jensenius M, Norheim I (2001)
   [A woman with Addison's disease and a bump on the neck]
   Tidsskr Nor Laegeforen, 121 (10), 1259, 1261
   PubMed 11402756
7. Gjeruldsen S, Abdelnoor M, Opjordsmoen S, Myrvang B (2001)
   Death rates and causes of death in cohorts of serum hepatitis patients followed up for more than 20 years
   Epidemiol Infect, 126 (1), 89-96
   PubMed 11293686
8. Goplen AK, Liestøl K, Dunlop O, Bruun JN, Maehlen J (2001)
   Dementia in AIDS patients in Oslo; the role of HIV encephalitis and CMV encephalitis
   Scand J Infect Dis, 33 (10), 755-8
   PubMed 11728043
9. Haug JB (2001)
   [Dangerous bacterial conditions]
   Tidsskr Nor Laegeforen, 121 (28), 3262
   PubMed 11826454
10. Kirk O, Mocroft A, Pradier C, Bruun JN, Hemmer R, Clotet B, Miller V, Viard JP, Phillips AN, Lundgren JD, EuroSIDA Study Group (2001)
    Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir
    AIDS, 15 (8), 999-1008
    PubMed 11399982
11. Oktedalen O, Solberg EE, Haugen AH, Opstad PK (2001)
    The influence of physical and mental training on plasma beta-endorphin level and pain perception after intensive physical exercise
    Stress Health, 17 (2), 121-127
12. Ormaasen V, Brantsaeter AB, Moen EW (2001)
    [Tick-borne encephalitis in Norway]
    Tidsskr Nor Laegeforen, 121 (7), 807-9
    PubMed 11301704
13. Ormaasen V, Bruun JN (2001)
    [Antiviral therapy of HIV infection in adults]
    Tidsskr Nor Laegeforen, 121 (29), 3414-20
    PubMed 11826789
14. Ormaasen V, Maeland A (2001)
    [Tuberculosis among HIV-infected persons in Norway]
    Tidsskr Nor Laegeforen, 121 (29), 3425-30
    PubMed 11826791
15. Os I, Ström EH, Stenehjem A, Gudmundsdottir H, Langberg H, Draganov B, Godøy J, Dunlop O, von der Lippe B (2001)
    Varicella infection in a renal transplant recipient associated with abdominal pain, hepatitis, and glomerulonephritis
    Scand J Urol Nephrol, 35 (4), 330-3
    PubMed 11676362
16. Raoult D, Fournier PE, Fenollar F, Jensenius M, Prioe T, de Pina JJ, Caruso G, Jones N, Laferl H, Rosenblatt JE, Marrie TJ (2001)
    Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa
    N Engl J Med, 344 (20), 1504-10
    PubMed 11357153
17. Svendsen J, Ormaasen V, von der Lippe E, Jacobsen D (2001)
    [Two cases of pneumococcal pericarditis]
    Tidsskr Nor Laegeforen, 121 (15), 1801-3
    PubMed 11464685
18. Viard JP, Mocroft A, Chiesi A, Kirk O, Røge B, Panos G, Vetter N, Bruun JN, Johnson M, Lundgren JD, EuroSIDA Study Group (2001)
    Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study
    J Infect Dis, 183 (8), 1290-4
    PubMed 11262215

Publications 2000

1. Brubakk O, Myrvang B (2000)
   [Non-practical guidelines?]
   Tidsskr Nor Laegeforen, 120 (26), 3196
   PubMed 11109372
2. Bøyum A, Tennfjord VA, Gran C, Løvhaug D, Oktedalen O, Brandtzaeg P (2000)
   Bioactive cytidine deaminase, an inhibitor of granulocyte-macrophage colony-forming cells, is massively released in fulminant meningococcal sepsis
   J Infect Dis, 182 (6), 1784-7
   PubMed 11069255
3. Dyrhol-Riise AM, Brantsaeter AB, Dunlop O, Baklien K, Skar AG, Asjö B, Bruun JN, Røsok BI (2000)
   Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals
   Scand J Immunol, 51 (2), 195-201
   PubMed 10652164
4. Dyrhol-Riise AM, Voltersvik P, Røsok BI, Olofsson J, Asjö B (2000)
   Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection
   AIDS Res Hum Retroviruses, 16 (3), 191-201
   PubMed 10710207
5. Jensenius M, Høiby EA, Berild D, Stiris M, Ringertz SH (2000)
   Difficulties in diagnosing Brucella spondylitis
   Scand J Infect Dis, 32 (4), 425-6
   PubMed 10959656
6. Jensenius M, Løvstad RZ, Dhaenens G, Rørvik LM (2000)
   A heroin user with a wobbly head
   Lancet, 356 (9236), 1160
   PubMed 11030296
7. Jonassen TO, Grinde B, Asjö B, Hasle G, Hungnes O (2000)
   Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases
   AIDS Res Hum Retroviruses, 16 (1), 49-58
   PubMed 10628816
8. Liestøl K, Kvittingen EA, Rootwelt H, Dunlop O, Goplen AK, Pedersen JC, Brorson SH, Børresen-Dale AL, Myrvang B, Maehlen J (2000)
   Association between apolipoprotein E genotypes and cancer risk in patients with acquired immunodeficiency syndrome
   Cancer Detect Prev, 24 (5), 496-9
   PubMed 11129992
9. Løvstad RZ, Berntsen AG, Berild D, Stiris M (2000)
   [Intraspinal infections in patients treated with epidural analgesia]
   Tidsskr Nor Laegeforen, 120 (20), 2403-6
   PubMed 11475225
10. Mellgren A, Norkrans G, Hagberg L, Dunlop O, Wejstål R, Gisslén M (2000)
    Slowed reaction time in HIV-1-infected patients without AIDS
    Acta Neurol Scand, 102 (3), 169-74
    PubMed 10987376
11. Myrvang B (2000)
    [Malaria in Norway--diagnosis, treatment and prevention]
    Tidsskr Nor Laegeforen, 120 (14), 1648-52
    PubMed 10901075
12. Myrvang B, Godal T (2000)
    [WHO's malaria program Roll Back Malaria]
    Tidsskr Nor Laegeforen, 120 (14), 1661-4
    PubMed 10901078
13. Mørk C, Kalgaard OM, Myrvang B, Kvernebo K (2000)
    Erythromelalgia in a patient with AIDS
    J Eur Acad Dermatol Venereol, 14 (6), 498-500
    PubMed 11444274
14. Ringertz SH, Høiby EA, Jensenius M, Maehlen J, Caugant DA, Myklebust A, Fossum K (2000)
    Injectional anthrax in a heroin skin-popper
    Lancet, 356 (9241), 1574-5
    PubMed 11075776
15. Rønning EJ, Myrvang B, Jensenius M (2000)
    [Falciparum malaria in Oslo and Akerhus]
    Tidsskr Nor Laegeforen, 120 (14), 1658-60
    PubMed 10901077
16. Sindre H, Haraldsen G, Beck S, Hestdal K, Kvale D, Brandtzaeg P, Degré M, Rollag H (2000)
    Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection
    Scand J Immunol, 51 (4), 354-60
    PubMed 10736107
17. Strand OA, Leone A, Giercksky KE, Kirkebøen KA (2000)
    Nitric oxide indices in human septic shock
    Crit Care Med, 28 (8), 2779-85
    PubMed 10966250
18. Voltersvik P, Dyrhol-Riise AM, Bostad L, Røsok BI, Olofsson J, Asjö B (2000)
    Changes in tonsillar tissue in early HIV-1 infection and during 3 years of antiretroviral therapy
    APMIS, 108 (7-8), 539-50
    PubMed 11167551